Genmab A/S (GNMSF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2020 | 12-2019 | 09-2019 | 06-2019 | 03-2019 | |
| Sales | 131,748 | 442,924 | 154,937 | 116,551 | 89,952 |
| Gross Profit | 131,748 | 442,924 | 154,937 | 116,551 | 89,952 |
| Operating Expenses | 121,262 | 116,458 | 102,678 | 95,894 | 93,897 |
| Operating Income | 10,487 | 326,465 | 52,259 | 20,657 | -3,946 |
| Interest Expense | 295 | 48,971 | -51,933 | 4,012 | 0 |
| Other Income | 42,095 | 15,922 | 0 | 0 | 18,256 |
| Pre-tax Income | 52,286 | 293,416 | 104,193 | 16,646 | 14,310 |
| Income Tax | 12,555 | 72,526 | 24,173 | 3,862 | 3,320 |
| Net Income Continuous | 39,731 | 220,890 | 80,020 | 12,784 | 10,990 |
| Net Income | $39,731 | $220,890 | $80,020 | $12,784 | $10,990 |
| EPS Basic Total Ops | 0.61 | 3.52 | 1.25 | 0.21 | 0.18 |
| EPS Basic Continuous Ops | 0.61 | 3.52 | 1.25 | 0.21 | 0.18 |
| EPS Diluted Total Ops | 0.60 | 3.49 | 1.23 | 0.20 | 0.18 |
| EPS Diluted Continuous Ops | 0.60 | 3.49 | 1.23 | 0.20 | 0.18 |
| EBITDA(a) | $10,487 | $326,465 | $52,259 | $20,657 | $-3,946 |